Sunday, March 15th from 9:30 am - 10:00 am PDT

The Expanding Role of FcRn Blockers to Achieve Minimal Symptom Expression in Patients with Generalized Myasthenia Gravis

A CME Symposium in Conjunction with the San Francisco Neurological Society